Dehydroeburicoic acid monoacetateCAS# 77035-42-8 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 77035-42-8 | SDF | Download SDF |
PubChem ID | 15250827.0 | Appearance | Powder |
Formula | C33H50O4 | M.Wt | 510.75 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2R)-2-[(3S,5R,10S,13R,14R,17R)-3-acetyloxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid | ||
SMILES | CC(C)C(=C)CCC(C1CCC2(C1(CC=C3C2=CCC4C3(CCC(C4(C)C)OC(=O)C)C)C)C)C(=O)O | ||
Standard InChIKey | AYHCPTDPDUADTK-DLCVLMBDSA-N | ||
Standard InChI | InChI=1S/C33H50O4/c1-20(2)21(3)10-11-23(29(35)36)24-14-18-33(9)26-12-13-27-30(5,6)28(37-22(4)34)16-17-31(27,7)25(26)15-19-32(24,33)8/h12,15,20,23-24,27-28H,3,10-11,13-14,16-19H2,1-2,4-9H3,(H,35,36)/t23-,24-,27+,28+,31-,32-,33+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Dehydroeburicoic acid monoacetate Dilution Calculator
Dehydroeburicoic acid monoacetate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.9579 mL | 9.7895 mL | 19.5791 mL | 39.1581 mL | 48.9476 mL |
5 mM | 0.3916 mL | 1.9579 mL | 3.9158 mL | 7.8316 mL | 9.7895 mL |
10 mM | 0.1958 mL | 0.979 mL | 1.9579 mL | 3.9158 mL | 4.8948 mL |
50 mM | 0.0392 mL | 0.1958 mL | 0.3916 mL | 0.7832 mL | 0.979 mL |
100 mM | 0.0196 mL | 0.0979 mL | 0.1958 mL | 0.3916 mL | 0.4895 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- ThonningianinB
Catalog No.:BCX0954
CAS No.:271579-12-5
- (25R)-Spirost-4-en-3,12-dion
Catalog No.:BCX0953
CAS No.:6875-60-1
- Nitidine
Catalog No.:BCX0952
CAS No.:6872-57-7
- SpicatosideA
Catalog No.:BCX0951
CAS No.:128397-47-7
- Nepetin7-O-β-D-glucopyranoside
Catalog No.:BCX0950
CAS No.:1627598-00-8
- Aromaticin
Catalog No.:BCX0949
CAS No.:5945-42-6
- Carpesiolin
Catalog No.:BCX0948
CAS No.:63568-73-0
- MangostanaxanthoneIV
Catalog No.:BCX0947
CAS No.:2182593-73-1
- GarcixanthonesB
Catalog No.:BCX0946
CAS No.:2522597-99-3
- 11-hydroxy-1-isomangostin
Catalog No.:BCX0945
CAS No.:164365-71-3
- CompoundK
Catalog No.:BCX0944
CAS No.:160729-91-9
- Lycobetaineacetate
Catalog No.:BCX0943
CAS No.:61221-41-8
- 10-Hydroxycamptothecin acetate
Catalog No.:BCX0956
CAS No.:951770-22-2
- Liquiritigenin-7-O-apiosyl(1-2)-glucoside
Catalog No.:BCX0957
CAS No.:135432-48-3
- Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one,5,8,8a,9-tetrahydro-5-(3,4,5-trimethoxyphenyl)- (9CI)
Catalog No.:BCX0958
CAS No.:69222-20-4
- 1,5-di-O-p-coumaroylquinicacid
Catalog No.:BCX0959
CAS No.:1239620-73-5
- 1-O-trans-caffeoyl-5-O-trans-p-coumaroylquinicacid
Catalog No.:BCX0960
CAS No.:1401532-34-0
- 1-p-coumaroyl-3-caffeoylquinicacid
Catalog No.:BCX0961
CAS No.:2459224-35-0
- IsochlorogenicacidA 3,5-Dicaffeoylquinicacid
Catalog No.:BCX0962
CAS No.:89919-62-0
- Glyurallin B
Catalog No.:BCX0963
CAS No.:199331-53-8
- Gancaonin L
Catalog No.:BCX0964
CAS No.:129145-50-2
- Cyanidin3-O-(6-(E)-Feruloyl)-β-D-glucopyranoside-(2-O-(E)-sinapoyl-β-D-glucopyranosyl)-β-D-glucopyranosyl-5-glucopyranoside
Catalog No.:BCX0965
CAS No.:765863-34-1
- Cyanidin3-O-(6-O-(E)-Feruloyl-β-D-glucopyranosyl(2-O-(E)-Feruloyl-β-D-glucopyranosyl)-glucopyranoside-5-O-glucopyranoside
Catalog No.:BCX0966
CAS No.:942192-63-4
- Cyanidin3-(6-(2-(p)-coumarate-β-D-glucopyranosyl)-β-D-glucopyranosyl)-5-glucopyranoside
Catalog No.:BCX0967
CAS No.:771448-35-2
Cytotoxic Constituents from the Sclerotia of Poria cocos against Human Lung Adenocarcinoma Cells by Inducing Mitochondrial Apoptosis.[Pubmed:30149516]
Cells. 2018 Aug 24;7(9):116.
Previous studies have revealed the antitumor potential of Poria cocos Wolf against a broad spectrum of cancers. However, the biological activity of P. cocos against lung cancer, which is known as the leading cause of cancer mortality worldwide, and its underlying chemical and molecular basis, remain to be investigated. We aimed to evaluate the in vitro cytotoxicity of P. cocos toward human lung adenocarcinoma cells with different p53 statuses, to identify the bioactive constituents of P. cocos, and explicate the molecular mechanisms underlying the cytotoxicity of these constituents in human lung adenocarcinoma cells. An EtOH extract of the sclerotia of P. cocos exhibited cytotoxicity toward four human lung cancer cell lines: A549, H1264, H1299, and Calu-6, regardless of their p53 status. Chemical investigation of the extract resulted in the isolation of two triterpenoids, Dehydroeburicoic acid monoacetate (1) and acetyl eburicoic acid (4); a sterol, 9,11-dehydroergosterol peroxide (2); and a diterpenoid, dehydroabietic acid (3). All of the isolated compounds were cytotoxic to the lung adenocarcinoma cell lines, exhibiting IC(50) values ranging from 63.6 muM to 171.0 muM at 48 h of treatment. The cytotoxicity of the extract and the isolated compounds were found to be mediated by apoptosis, and accompanied by elevated Bax expression and/or Bcl-2 phosphorylation along with caspase-3 activation. Our data demonstrate that the sclerotium of P. cocos and its four bioactive constituents (1(-)4) exert cytotoxicity against human lung adenocarcinoma cells, regardless of their p53 status, by inducing apoptosis associated with mitochondrial perturbation, and proposing the potential to employ P. cocos in the treatment of lung cancer.
Bioactive compounds from sclerotia extract of Poria cocos that control adipocyte and osteoblast differentiation.[Pubmed:30092384]
Bioorg Chem. 2018 Dec;81:27-34.
Poria cocos Wolf confers edible sclerotia also known as 'Indian bread' in North America, that have been used for the treatment of various diseases in Asian countries. As part of our ongoing aim to identify biologically new metabolites from Korean edible mushrooms, we investigated the ethanol (EtOH) extract of the sclerotia of P. cocos by applying a comparative LC/MS- and bioassay-based analysis approach, since the EtOH extract reciprocally regulated adipocyte and osteoblast differentiation in mouse mesenchymal stem cells (MSCs). Bioassay-based analysis of the EtOH extract led to the successful isolation of two sterols, ergosterol peroxide (1) and 9,11-dehydroergosterol peroxide (2); three diterpenes, dehydroabietic acid (3), 7-oxocallitrisic acid, (4) and pimaric acid (5); and two triterpenes, Dehydroeburicoic acid monoacetate (6) and eburicoic acid acetate (7) from the active hexane-soluble fraction. The isolated compounds (1-7) were examined for their effects on the regulation of MSC differentiation. The two sterols (1 and 2) were able to suppress MSC differentiation toward adipocytes. In contrast, the three diterpenes (3-5) showed activity to promote osteogenic differentiation of MSC. These findings demonstrate that the EtOH extract of P. cocos sclerotia is worth consideration as a new potential source of bioactive compounds effective in the treatment of osteoporosis in the elderly, since the extract contains sterols that inhibit adipogenic differentiation as well as diterpenes that promote osteogenic differentiation from MSCs.
Protective effect of lanostane triterpenoids from the sclerotia of Poria cocos Wolf against cisplatin-induced apoptosis in LLC-PK1 cells.[Pubmed:28487074]
Bioorg Med Chem Lett. 2017 Jul 1;27(13):2881-2885.
Cisplatin-induced nephrotoxicity is a serious adverse effect that limits the use of cisplatin in cancer patients. In the present study, we investigated the protective effect of lanostane triterpenoids (1-10) isolated from the ethanolic extract of Poria cocos Wolf against cisplatin-induced cell death in LLC-PK1 kidney tubular epithelial cells. Treatment of cisplatin induced significant cell death, which was suppressed by treatment with Dehydroeburicoic acid monoacetate (1) and 3beta-acetoxylanosta-7,9(11),24-trien-21-oic acid (9). Compound 1 exhibited the highest efficacy among the tested compounds and was thus subjected to further mechanistic studies. The increase in the percentage of apoptotic cells induced by cisplatin reduced by 4.3% after co-treatment of cells with compound 1 (50 and 100muM). Furthermore, phosphorylation of the mitogen-activated protein kinases JNK, ERK, and p38, and caspase-3, which characterize oxidative stress-mediated apoptosis, increased significantly after treatment with cisplatin, and decreased after treatment with compound 1. These results indicate that the renoprotective effects of compound 1 may be mediated by its anti-apoptotic activity.